Nuclide Therapeutics Ltd
15734758
Some Concerns
- Negative net worth (-10)
- 1 outstanding charge (-2)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 13/06/2024
SCIENTIST
PORTUGUESE · UNITED KINGDOM · Age 40
Persons with Significant Control
Former PSCs
Dr Richard Sherburne Edwards
Ceased 13/06/2024
Dr Timothy Howard Witney
Ceased 13/06/2024
Charges1 outstanding
HSBC INNOVATION BANKING
CompanyRankvs 3793+ SIC 72110 peers14
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2025
Net Worth
-£173
Balance sheet strength
Cash
£26
Cash in the bank
Net Current Assets
-£173
Working capital
Current Assets
£26
Current Liabilities
£199
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2025 | 0.13 |
| 2025 | 0.13 |
Derived from filed accounts. Not audited figures.